Filing Flows › Gossamer Bio (GOSS) › Stock forecast & fair value
Gossamer Bio (GOSS) stock forecast and price target
Gossamer Bio (GOSS) trades at $9.77. 6 analysts' median price target is $95.00 (+872%), from $22.40 to $160.00.
Gossamer Bio's latest quarter
Gossamer Bio, Q2 2026: revenue $9.2M (-20% year over year), operating margin -282.2%, net earnings $16.9M, operating cash flow −$39.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for GOSS stock?
The median of 6 analysts' 12-month targets is $95.00, +872% from $9.77; the range is $22.40 to $160.00. The average rating is buy.
Does Gossamer Bio usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is GOSS stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.